PUBLISHER: GlobalData | PRODUCT CODE: 1410739
PUBLISHER: GlobalData | PRODUCT CODE: 1410739
Vertebral Body Replacement (VBR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on the Vertebral Body Replacement (VBR) Systems Devices market for the year 2020 and beyond. Decompression of the spinal cord and nerves which is a result of bone fractures and dislocation of bones, all kinds of tumors like primary & metastatic tumors, and benign & malignant tumors are the leading causes for treatments necessitating the use of VBR Systems. Although the prevalence of these indications varies globally, usage of VBR Devices is universally impacted by thePaging population.
Amongst the indications driving the market for VBR, the most common ailment is back pain the others include degenerative disc disease, spinal deformity and change in lifestyle. Also increasing aging population which results in an increasing osteoporotic patient pool can be a market driver as this is a primary cause of spinal fractures. The indications necessitating the use of VBR Systems, can be treated by using either cervical fusion procedures or thoraco-lumbar fusion procedures along with VBR systems.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Vertebral Body Replacement (VBR) Systems Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc,DePuy Synthes Inc, ZimVie Inc, Stryker Corp, Globus Medical Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable